Fatty Liver In Kwashiorkor
Published on: July 28, 2025
Fatty liver cartoon character
Article author photo

Jayasree Ramesh

Doctor Of Pharmacy

Article reviewer photo

Menar Albesheir

Msc Physician Associate Studies; Bsc Biomedical Science

Introduction

Kwashiorkor is a severe form of protein-energy malnutrition predominantly affecting children in low-resource settings. One of its hallmark complications is the development of fatty liver, or hepatic steatosis, which significantly impacts morbidity and mortality. Understanding the mechanisms, clinical implications, and management of fatty liver in kwashiorkor is essential for effective care and prevention.

Understanding kwashiorkor

Kwashiorkor is a type of severe acute malnutrition characterised by oedema, irritability, enlarged fatty liver, skin changes, and hair discolouration. It typically results from a diet that is adequate in calories but deficient in protein.1,3

Epidemiology

Kwashiorkor primarily affects children in regions with food insecurity, especially in Sub-Saharan Africa, parts of Asia, and Latin America. It often occurs after weaning, when children transition from breast milk to a carbohydrate-rich, protein-poor diet.3

Clinical features

Key features of kwashiorkor include:

  • Generalised oedema
  • Dermatoses (skin changes)
  • Hair changes (depigmentation, thinning)
  • Hepatomegaly (enlarged liver)
  • Apathy and irritability
  • Poor growth and muscle wasting1,3

Fatty liver in kwashiorkor

Pathophysiology

Fatty liver or hepatic steatosis is a common finding in kwashiorkor. The liver becomes enlarged due to the accumulation of fat, especially triglycerides, within hepatocytes.1,3 This is primarily the result of impaired synthesis of β-lipoproteins, which are essential for the export of triglycerides from the liver.1,5

Mechanisms of fat accumulation

Several mechanisms contribute to hepatic steatosis in kwashiorkor:

  • Decreased β-lipoprotein synthesis: without adequate protein, the liver cannot produce the proteins necessary to form lipoproteins, leading to impaired export of triglycerides1,5
  • Increased mobilisation of free fatty acids: poor nutrition and stress increase the release of free fatty acids from adipose tissue, which are then taken up by the liver5
  • Decreased fatty acid oxidation: Malnutrition impairs the liver’s ability to oxidise fatty acids, further promoting fat accumulation5
  • Possible deficiency of lipotropic factors: nutritional deficiencies in methionine and choline may also contribute, though this remains less clearly established in humans5

Differences from other fatty liver diseases

Unlike non-alcoholic fatty liver disease (NAFLD) or alcoholic liver disease, fatty liver in kwashiorkor is primarily due to protein deficiency and impaired lipoprotein synthesis, rather than excess caloric intake or alcohol toxicity.10

Clinical manifestations of kwashiorkor

Signs and symptoms

Fatty liver in kwashiorkor often presents with:

  • Hepatomegaly (palpable, enlarged liver)
  • Abdominal distension
  • Loss of appetite
  • Fatigue and weakness1,3,7

Diagnostic approaches

Diagnosis of kwashiorkor is based on clinical findings, supported by laboratory tests and imaging, such as:

  • Physical examination: enlarged liver on palpation1,3
  • Serum biochemistry: low serum albumin, low cholesterol, and altered lipid profiles5,8
  • Imaging: ultrasound or CT scan may show hepatic steatosis
  • Liver biopsy: confirms macrovesicular steatosis (fat droplets in hepatocytes)10

Biochemical and histological findings

Serum lipids and lipoproteins

Children with kwashiorkor and fatty liver typically exhibit:

  • Low serum triglycerides and cholesterol
  • Markedly reduced β-lipoprotein levels
  • Variable increases in plasma free fatty acids before treatment 5,8

Liver biopsy and imaging

Histology reveals:

  • Macrovesicular steatosis (large fat droplets in liver cells)
  • Minimal inflammation or fibrosis in the early stages
  • Fat accumulation, predominantly as triglycerides10

Management and treatment for kwashiorkor

Nutritional rehabilitation

  • Protein repletion: Is essential to restore β-lipoprotein synthesis and reverse hepatic steatosis2,3
  • Caloric support: Calories should be increased slowly to avoid refeeding syndrome2
  • Micronutrient supplementation: Correction of vitamin and mineral deficiencies is important2

Supportive and adjunctive therapies

  1. Monitoring for complications: Such as infections, electrolyte imbalances, and heart failure
  2. Management of oedema: Careful fluid management is crucial
  3. Liver support: There is no specific pharmacological therapy for fatty liver in kwashiorkor; improvement depends on nutritional recovery6,9

Prognosis

With appropriate intervention, fatty liver in kwashiorkor is reversible. However, delayed treatment can lead to liver failure, infections, and increased mortality.3,1

Prevention and public health implications of kwashiorkor

Prevention strategies include:

  • Promoting breastfeeding and appropriate complementary feeding
  • Ensuring food security and access to protein-rich foods
  • Community education on balanced nutrition
  • Early identification and treatment of at-risk children3,1

Conclusion

Fatty liver is a frequent and notable feature in children suffering from kwashiorkor, a form of severe protein-calorie malnutrition. The accumulation of fat in the liver, primarily as triglycerides, is attributed to multiple metabolic disturbances, including impaired synthesis of lipoproteins due to protein deficiency, increased mobilisation of free fatty acids from the adipose tissue, and possible defects in fatty acid oxidation or release from the liver.2,5,8 While the exact mechanisms remain complex, evidence suggests that reduced hepatic production of proteins necessary for fat export plays a central role in the pathogenesis of fatty liver in kwashiorkor.2,5

Clinically, not all cases of kwashiorkor present with fatty liver, and the severity can vary widely, sometimes even occurring in marasmus or being absent in kwashiorkor. Biochemical markers such as low serum cholesterol and albumin are commonly associated with more severe liver involvement. Understanding these mechanisms is crucial for effective management and nutritional rehabilitation of affected children, as timely intervention can reverse both the clinical and biochemical abnormalities associated with fatty liver in kwashiorkor.5,8

Summary

Fatty liver in kwashiorkor is a multifactorial problem rooted in protein deficiency and metabolic imbalance, highlighting the importance of early recognition and comprehensive nutritional support for affected individuals.

FAQs

Why does fatty liver develop in kwashiorkor? 

Fatty liver in kwashiorkor develops due to impaired synthesis of β-lipoproteins in the liver, which are necessary for exporting triglycerides. Protein deficiency disrupts this process, leading to fat accumulation in hepatocytes.

How is fatty liver in kwashiorkor diagnosed? 

Diagnosis is based on clinical signs (enlarged liver), laboratory findings (low serum proteins and lipids), and imaging or biopsy confirming hepatic steatosis.

Is fatty liver in kwashiorkor reversible?

Yes, with prompt and adequate nutritional rehabilitation, fatty liver in kwashiorkor is usually reversible.

How is treatment different from other fatty liver diseases?  

Treatment focuses on protein and calorie repletion, rather than weight loss or avoidance of alcohol, which are mainstays in other forms of fatty liver disease.

Can fatty liver in kwashiorkor lead to long-term liver damage?  

If untreated, it can progress to liver failure and increase the risk of infections and death, but with timely intervention, long-term damage is uncommon.

References

  1. Kwashiorkor - an overview | ScienceDirect Topics [Internet]. [cited 2025 May 15]. Available from: https://www.sciencedirect.com/topics/nursing-and-health-professions/kwashiorkor
  2. May T, Klatt KC, Smith J, Castro E, Manary M, Caudill MA, et al. Choline Supplementation Prevents a Hallmark Disturbance of Kwashiorkor in Weanling Mice Fed a Maize Vegetable Diet: Hepatic Steatosis of Undernutrition. Nutrients [Internet]. 2018 [cited 2025 May 15]; 10(5):653. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986532/
  3. Frenk S, Gómez F, Ramos-galván R, Cravioto J. Fatty Liver in Children—Kwashiorkor. The American Journal of Clinical Nutrition [Internet]. 1958 [cited 2025 May 15]; 6(3):298–309. Available from: https://www.sciencedirect.com/science/article/pii/S0002916523150738
  4. Antunes C, Azadfard M, Hoilat GJ, Gupta M. Fatty Liver. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 May 15]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK441992/
  5.  Kapoor DD. Fatty liver: Causes, symptoms, treatment & prevention. The Times of India [Internet]. [cited 2025 May 15]. Available from: https://timesofindia.indiatimes.com/blogs/voices/fatty-liver-causes-symptoms-treatment-prevention/
  6. Truswell AS, Hansen JDL, Watson CE, Wannenburg P. Relation of Serum Lipids and Lipoproteins to Fatty Liver in Kwashiorkor. The American Journal of Clinical Nutrition [Internet]. 1969 [cited 2025 Jul 28]; 22(5):568–76. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002916523323049 
  7. El-Kader SMA, Ashmawy EMSE-D. Non-alcoholic fatty liver disease: The diagnosis and management. World Journal of Hepatology [Internet]. 2015 [cited 2025 May 15]; 7(6):846–58. Available from: https://www.wjgnet.com/1948-5182/full/v7/i6/846.htm
  8. Nonalcoholic Fatty Liver Disease [Internet]. 2024 [cited 2025 May 15]. Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/nonalcoholic-fatty-liver-disease
Share

Jayasree Ramesh

Doctor Of Pharmacy

As a registered and licensed clinical pharmacist with a PharmD degree, I'm passionate about advancing pharmaceutical research and contributing to evidence-based practice.

arrow-right